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ABSTRACT
Objective Fetal megacystis presents a challenge in terms
of counseling and management because of its varied
etiology and evolution. The aim of this study was to
present a comprehensive overview of the underlying
etiologies and structural anomalies associated with fetal
megacystis.
Methods This was a retrospective multicenter study of
cases referred to the fetal medicine unit of one of the eight
academic hospitals in The Netherlands with a diagnosis of
fetal megacystis. For each case, data on and measurements
of fetal urinary tract and associated structural anomalies
were collected. All available postmortem examinations
and postnatal investigations were reviewed in order to
establish the final diagnosis. In the first trimester, fetal
megacystis was defined as longitudinal bladder diameter
(LBD) ≥ 7 mm, and in the second and third trimesters as
an enlarged bladder failing to empty during an extended
ultrasound examination lasting at least 40 min.
Results Of the 541 pregnancies with fetal megacystis,
it was isolated (or solely accompanied by other signs
of lower urinary tract obstruction (LUTO)) in 360
(67%) cases and associated with other abnormal
ultrasound findings in 181 (33%) cases. The most
common associated ultrasound anomaly was an increased
nuchal translucency thickness (22%), followed by single
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umbilical artery (10%) and cardiac defect (10%). A
final diagnosis was established in 418 cases, including
222 (53%) cases with isolated LUTO and 60 (14%)
infants with normal micturition or minor isolated
urological anomalies. In the remaining 136 (33%) cases,
concomitant developmental or chromosomal abnormality
or genetic syndrome was diagnosed. Overall, 40
chromosomal abnormalities were diagnosed, including
trisomy 18 (n = 24), trisomy 21 (n = 5), Turner syndrome
(n = 5), trisomy 13 (n = 3) and 22q11 deletion (n = 3).
Thirty-two cases presented with anorectal malformations
involving the anus, rectum and urogenital tract. In cases
with confirmed urethral and anal atresia, megacystis
occurred early in pregnancy and the bladder appeared
severely distended (the LBD (in mm) was equal to or
greater than twice the gestational age (in weeks)). Fetal
macrosomia was detected in six cases and an overgrowth
syndrome was detected in four cases, comprising two
infants with Beckwith–Wiedemann syndrome and two
with Sotos syndrome. Megacystis-microcolon-intestinal
hypoperistalsis syndromewas diagnosed in five (1%) cases
and prenatally suspected only in one case.
Conclusions Although the main cause of fetal megacystis
is LUTO, an enlarged fetal bladder can also be present
as a concomitant finding of miscellaneous genetic syn-
dromes, developmental disturbances and chromosomal
abnormalities. We provide an overview of the structural
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anomalies and congenital disorders associated with fetal
megacystis and propose a practical guide for the differ-
ential diagnosis of genetic syndromes and chromosomal
and developmental abnormalities in pregnancies present-
ing with fetal megacystis, focusing on the morphological
examination of the fetus. © 2018 The Authors. Ultra-
sound in Obstetrics & Gynecology published by John
Wiley & Sons Ltd on behalf of the International Society
of Ultrasound in Obstetrics and Gynecology.
INTRODUCTION
Fetal urine production begins at about 10 weeks’
gestation, when the urinary bladder can be identified
as an anechoic structure within the fetal pelvis, surrounded
by the two umbilical arteries1. The finding of a distended
urinary bladder, also known as fetal megacystis, is easily
accomplished on ultrasound but difficult to manage owing
to its varied etiology and uncertain evolution. In the
first trimester, fetal megacystis is defined as longitudinal
bladder diameter (LBD) ≥ 7 mm, and is present in 0.06%
of pregnancies2. Beyond the first trimester, the prevalence
of megacystis remains unclear and its definition is still
ambiguous3.
The main cause of fetal megacystis, diagnosed
in any trimester of pregnancy, is bladder outlet
obstruction, also known as lower urinary tract obstruction
(LUTO)4–6. In cases with severe early megacystis,
parents often choose to terminate the pregnancy. In
less severe cases with early megacystis (LBD ≤ 12 mm)
and negative work-up, a spontaneous resolution often
occurs4,6,7. In fetuses surviving the second half of
pregnancy, LUTO commonly leads to hydronephrosis,
renal dysplasia and severe oligohydramnios, with a known
poor prognosis. However, besides isolated LUTO, the
differential diagnosis of fetal megacystis should also
include chromosomal abnormalities, genetic syndromes
and developmental anomalies. The wide spectrum of
etiologies and prognoses makes the counseling and
management of this condition particularly challenging8.
Given the low prevalence of fetal megacystis9,10 and
the main focus on LUTO as etiology, the other causes
of enlarged fetal bladder have, thus far, been poorly
investigated.
The main aim of this study was to present a
comprehensive overview of the underlying etiologies and
structural anomalies associated with fetal megacystis and
to identify patterns of anomalies and ultrasound features
related to specific complex anomalies and syndromes,
beyond LUTO.
METHODS
This study was part of a large retrospective multicenter
study carried out at the fetal medicine units (FMUs)
of all eight academic hospitals in The Netherlands
that act as referral centers for fetal anomalies detected
on ultrasound examination. Data on cases with a
diagnosis of fetal megacystis were retrieved from
local databases, from the time at which registration
in each database had started (between 2000 and 2014
at Erasmus Medical Center and Academic Medical
Center, Amsterdam, and at University Medical Center,
Maastricht; between 2004 and 2015 at University Medical
Center Groningen, Groningen, and at Radboud University
Medical Center, Nijmegen; and between 2007 and 2014
in the remaining centers). In the first trimester, fetal
megacystis was defined as a fetal bladder with LBD of
≥ 7 mm, and in the second and third trimesters as an
enlarged bladder failing to empty during an extended
ultrasound examination lasting at least 40 min2,11.
In The Netherlands, all cases suspected of fetal
megacystis are referred to the FMU of one of the eight
academic hospitals for confirmation of the diagnosis and
further investigation. Cases were referred after either a
dating scan, first-trimester scan, 20-week anomaly scan
or after a scan performed for other indications later in
pregnancy. All cases had undergone a detailed anomaly
scan, except for those pregnancies that did not reach the
18th week of gestation (n= 142, including 115 terminated
pregnancies and 27 miscarriages). Parents were counseled
about the prognosis of the condition and informed about
the possibility of in-utero treatment. Vesicoamniotic shunt
placement was only offered to chromosomally normal
male fetuses with isolated signs of LUTO and with
concomitant oligohydramnios.
For each case, prenatal data regarding gestational
age (GA) at diagnosis, LBD and associated ultrasound
findings were retrieved. The LBD was obtained from
a midsagittal view of the fetus, by measuring the
distance from the fetal bladder dome to the bladder
neck. Ultrasound findings typically associated with
LUTO, such as hydronephrosis, abnormal renal cortical
appearance, keyhole sign and oligohydramnios (with
eventual compression deformities), were not regarded
as associated ultrasound anomalies. Nuchal translucency
(NT) was considered increased if it was greater than the
95th percentile according to GA12. For cases referred in the
first trimester of pregnancy, we considered NT measured
at referral, while in fetuses referred later in pregnancy, we
collected the NT measurement retrospectively.
All available postmortem examinations and postnatal
investigations were reviewed in order to establish a
final diagnosis. LUTO was defined as a bladder outlet
obstruction caused by urethral valves, urethral stenosis or
urethral atresia. The term anorectal malformation (ARM)
was used to describe a group of complex congenital
anomalies characterized by an abnormal development
of the urorectal septum, resulting in congenital abnor-
malities of the distal anus, rectum and genitourinary
tract13. In this group, cloacal dysgenesis or cloacal
malformation was characterized by the absence of anal,
genital and urinary orifices14. VACTERL association
was diagnosed if three of the following criteria were
met: vertebral defects, anal atresia/imperforate anus,
cardiovascular anomalies, tracheoesophageal fistula or
esophageal atresia, renal anomalies and limb defects
(including radial anomalies) in at least two of the three
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regions involved (thorax, pelvis/lower abdomen and
limb)15. Caudal regression spectrum was defined as the
presence of abnormalities at the level of the caudal spinal
segments, ranging from minor sacrococcygeal malforma-
tions to complete absence of sacrum and lumbar spine16.
Omphalocele-exstrophy-imperforate anus-spinal defect
(OEIS) complex was diagnosed in cases of omphalocele
associated with bladder exstrophy, imperforate anus
and spinal defect17. Infants without LUTO or other
severe congenital abnormality or congenital syndrome
were included in the group with normal urinary tract or
isolated urological anomaly, such as vesicoureteral reflux
or duplex collecting system. Neonatal death was defined
as death of a liveborn during the first 28 completed days
postpartum. In case of isolated LUTO, the postnatal renal
function was evaluated based on the estimated glomeru-
lar filtration rate (eGFR); this was calculated using the
Schwartz formula, taking into account the infant’s length
and the creatinine nadir in the first year of age18.
RESULTS
During the study period, 541 pregnancies (25 twin
and 516 singleton pregnancies) were referred to one
of the eight FMUs in The Netherlands owing to the
finding of fetal megacystis. Of the 541 pregnancies, 233
(43%) were referred before the 18th week of gestation
(early megacystis) and 308 (57%) at or after the 18th
week of gestation (late megacystis) (Figure 1). This study
deals with structural anomalies, genetic syndromes and
developmental or chromosomal abnormalities associated
with fetal megacystis. Other outcome measures relative to
this cohort have been reported on in different studies4–6.
Fetal megacystis was isolated (or solely associated
with other signs of LUTO) in 360 (67%) pregnancies
and associated with other abnormal ultrasound findings
in 181 (33%). More than a single associated anomaly
was found in 70 cases, while a total of 292 associated
ultrasound findings were observed (Table 1). The most
common associated ultrasound anomaly was increased
NT (22%), followed by single umbilical artery (10%) and
cardiac defect (10%).
Overall 188 (35%) pregnancies were terminated, 50
(9%) resulted in intrauterine demise, 68 (13%) in neonatal
death and 235 (43%) children were alive beyond 28
days after birth. Of the terminated pregnancies, the
parents did not consent to postmortem examination
in 117 (62%) cases. Moreover, six cases were lost to
follow-up (Figure 1). Therefore, a final causal diagnosis
was possible in 418 (77%) cases. These included 222
(53%) cases with isolated LUTO, 60 (14%) infants
with a minor isolated urological anomaly or normal
micturition at birth, and 136 (33%) ‘syndromic’ cases
with miscellaneous chromosomal abnormality, genetic
syndrome or developmental anomaly (Table 2). The latter
group consisted of four categories: (1) fetuses with
major chromosomal abnormality (n = 40); (2) fetuses
with ARM (n= 32); (3) fetuses with macrosomia or
overgrowth genetic syndrome (n = 10); and (4) cases with
multiple congenital abnormalities or other miscellaneous
genetic syndrome (n= 54). Table 3 summarizes GA at
referral, LBD, fetal gender, pregnancy outcome and
findings at postnatal or postmortem investigation in
the syndromic cases. The outcome and postnatal renal
Diagnosis of fetal megacystis (n = 541):
  Early megacystis (< 18th week) (n = 233)
 Late megacystis (≥ 18th week) (n = 308)
Excluded (n = 123):
 Lost to follow-up (n = 6)
 PM not performed (n = 117)
Minor isolated urological
anomaly or normal
urinary tract (n = 60)
Pregnancy outcome (n = 541):
   TOP (n = 188)
 IUFD (n = 50)
   Neonatal death (n = 68)
   Alive beyond 28 days after birth
      (n = 235)
Final causal diagnosis (n = 418):
   Via PM (n = 139)
   Via prenatal evidence of MCA or
      abnormal karyotype (n = 50)
   Via postnatal examination (n = 229)
Miscellaneous
syndrome (n = 136)
Isolated LUTO
(n = 222)
Figure 1 Flowchart showing clinical diagnosis and outcome of 541
fetuses with fetal megacystis. IUFD, intrauterine fetal demise;
LUTO, lower urinary tract obstruction; MCA, multiple congenital
anomalies; PM, postmortem; TOP, termination of pregnancy.
Table 1 Details of additional 292 abnormal ultrasound findings
observed in 181 fetuses diagnosed with megacystis
Ultrasound finding n (%)
Nuchal translucency ≥ 95th centile 64 (22)
Single umbilical artery 30 (10)
Cardiac defect 30 (10)
Ventricular septal defect 3 (1)
Umbilical cord cyst 27 (9)
Spinal or skeletal anomaly 19 (6)
Sacrococcygeal teratoma 1 (0.3)
Abdominal wall defect 18 (6)
Urogenital anomaly 15 (5)
Intrauterine growth restriction 7 (2)
Macrosomia 6 (2)
Macroglossia 1 (0.3)
Central nervous system anomaly 5 (2)
Cleft lip/palate 3 (1)
Fetal hydrops 8 (3)
Diaphragmatic hernia 3 (1)
Choroid plexus cyst 15 (5)
Echogenic bowel 11 (4)
Short long bones 6 (2)
Ventriculomegaly 2 (0.7)
Echogenic intracardiac focus 2 (0.7)
Miscellaneous syndromal marker* 16 (5)
More than one finding was present in some fetuses. *Including
hypertelorism, strawberry skull, micrognathia and clubfoot.
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Table 2 Final diagnosis and gestational age (GA) at initial
diagnosis, in 418 pregnancies with fetal megacystis
Final diagnosis
n
(%)
GA
(weeks)
LUTO 222 (53) 22.6 ± 7
Normal micturition at birth or
minor isolated urological anomaly
60 (14) 21.7 ± 10
Miscellaneous congenital syndrome 136 (33) 18.8 ± 7
Major chromosomal abnormality 40 (10) 15.3 ± 4
Anorectal malformation 32 (8) 15.9 ± 5
Fetal macrosomia or overgrowth
syndrome
10 (2) 22.7 ± 8
MCA or other syndrome 54 (13) 20.0 ± 7
GA is given as mean ± SD. LUTO, lower urinary tract obstruction;
MCA, multiple congenital anomalies.
Table 3 Antenatal characteristics, outcome and postnatal/postmortem findings in pregnancies with fetal megacystis and associated
chromosomal or developmental abnormalities or genetic syndrome
Finding
GA at
referral
(weeks)
Mean
LBD
(mm)
Cases
with
LUTO
signs
Oligo-/an-
hydramnios Male sex Outcome
Associated
anomalies at
antenatal US
Findings at postmortem/
postnatal examination
Chromosomal abnormality
Trisomy 18 or
mosaicism (n = 24)
17
(12–29)
25 21 (88) 7 (29) 21 (88) 15 TOP;
9 PD
Increased NT, CHD,
UCC, omphalocele,
skeletal/spinal defect
CHD, agenesis of cerebellar
vermis, omphalocele,
clubfoot
Trisomy 21 (n = 5) 16
(13–22)
26 3 (60) 3 (60) 5 (100) 4 TOP;
1 PD
Increased NT, skeletal
anomaly
NA
Turner syndrome or
mosaicism (n = 5)
15
(11–21)
15 2 (40) 1 (20) 2 (40) 3 TOP;
1 PD; 1 AL
UCC, increased NT Imperforate anus, facial
dysmorphism, CHD
Trisomy 13 (n = 3) 12
(12–13)
9 3 (100) 0 (0) 3 (100) 3 TOP CHD, labiopalatoschisis,
SUA, polydactyly
NA
Deletion 22q11
syndrome (n = 3)
25
(12–37)
31 3 (100) 1 (33) 3 (100) 1 TOP;
2 AL
CHD Unilateral renal agenesis,
CHD, VUR
Total (n = 40) 17
(11–37)
23 32 (80) 12 (30) 34 (85) 26 TOP;
11 PD; 3 AL
Common features:
increased NT
Common features: CHD
Additional chromosomal abnormality with doubtful clinical significance
46,XY, 1.9 Mb
duplication, 19q13.33
de novo (n = 1)
NA NA 0 (0) 0 (0) 1 (100) AL UCC Delayed motor development,
muscular hypotonia,
gastroesophageal reflux;
ectopic testis, epiphyseal
dysplasia, short stature
46,XY, 22q11.2
microduplication +
14q31 duplication (n = 1)
37 NA 1 (100)* 1 (100) 1 (100) AL None PUV, severe VUR (grades
III–IV)
46,XX, deletion
5q.35.2 (n = 1)
19 NA 1 (100)† 1 (100) 0 (0) AL None Tethered cord, neurogenic
bladder, VUR,
multidysplastic kidneys,
psychomotor disability
46,X, der (X) t (X; Y)
(p22.33; p11.31) (n = 1)
21 13 1 (100)* 1 (100) 1 (100) AL None VUR, bilateral renal dys-
plasia, renal insufficiency,
46XX male
46,XY, t (14;16)
(q24.3; q24.1)pat (n = 1)
22 NA 1 (100)‡ 1 (100) NA TOP Unilateral renal agenesis
(left) and renal dysplasia
(right)
Unilateral renal agenesis (left)
and renal dysplasia (right)
Anorectal malformation
VACTERL (n = 13) 17
(11–31)
24 10 (77) 10 (77) 11 (85) 10 TOP;
3 PD
CHD, unilateral renal
agenesis, increased NT,
SUA, UCC, FEB
Anal atresia, cloacal anomaly,
unilateral renal agenesis,
CHD, colon-vesical fistula,
limb anomaly, esophageal
atresia, tethered cord, spina
bifida, vertebral defect
Cloacal
malformation (n = 6)
17
(13–22)
48 4 (67) 3 (50) 1 (17) 5 TOP;
1 PD
VSD, cystic hygroma,
UCC
Cloacal anomaly
Continued over.
function of cases with isolated LUTO are reported in
Table 4.
In total, 40 chromosomal abnormalities were diagnosed
(Tables 2 and 3), with a predominance of trisomy 18
(24 cases, including 22 with trisomy 18 and two with
trisomy 18 mosaicisms), followed by trisomy 21 (five
cases), Turner syndrome (five cases: one with Turner
syndrome and four with Turner mosaicism), trisomy
13 (three cases) and deletion 22q11 (three cases).
In the chromosomally abnormal fetuses, megacystis
was diagnosed at a mean GA of 17 weeks and
was associated with increased NT or other severe
structural anomalies. Amniotic fluid volume was normal
in 70% of cases. In addition, five fetuses presented with
miscellaneous chromosomal abnormalities of uncertain
© 2018 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2019; 53: 779–787.
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Table 3 Continued
Finding
GA at
referral
(weeks)
Mean
LBD
(mm)
Cases
with
LUTO
signs
Oligo-/an-
hydramnios Male sex Outcome
Associated
anomalies at
antenatal US
Findings at postmortem/
postnatal examination
OEIS (n = 7) 12
(11–14)
19 2 (29) 2 (29) 5 (71) 6 TOP;
1 PD
Omphalocele, SUA,
increased NT
Cloacal anomaly, cloacal
exstrophy, limb anomaly,
spina bifida, renal agenesis
CRS (n = 4) 14
(12–17)
25 1 (25) 4 (100) 2 (50) 3 TOP;
1 PD
Unilateral renal agenesis,
sirenomelia, spina
bifida, SUA
Sacral agenesis, hypoplasia of
lower extremities
Fraser syndrome (n = 2) 21
(21–22)
68 2 (100) 2 (100) 1 (50) 2 TOP Overgrowth,
hypertelorism, clubfoot,
increased NT, renal
agenesis
Renal agenesis, syndactyly,
imperforate anus, facial
dysmorphism
Total (n = 32) 16
(11–22)
29 23 (72) 21 (66) 20 (63) 26 TOP;
6 PD
Common features: SUA,
increased NT, UCC,
renal agenesis
Common features:
imperforate anus/anal
agenesis, cloacal anomaly,
spinal defect, limb
anomaly
Overgrowth syndrome or fetal macrosomia
BWS (n = 2) 22
(21–22)
35 2 (100) 1 (50) 2 (100) 1 TOP;
1 AL
Fetal overgrowth,
macroglossia,
hepatomegaly, skeletal
dysplasia
PUV, skeletal dysplasia
Sotos syndrome (n = 2) 24
(17–30)
NA 0 (0) 1 (50)§ 2 (100) 1 TOP;
1 AL
Polyhydramnios NA
Unknown cause (n = 5) 17
(12–35)
20 2 (40) 1 (20)¶ 5 (100) 2 TOP;
3 AL
EFW > 90th centile VUR, congenital megaureter
Cantu syndrome (n = 1) 21 15 1 (100) 0 (0)§ 1 (100) 1 AL Polyhydramnios, EFW
> 90th centile
VUR, facial dysmorphism,
PAS
Total (n = 10) 22
(12–35)
27 5 (50) 6 (60) 10 (100) 4 TOP;
6 AL
Common features: fetal
overgrowth,
polyhydramnios
Common features: VUR, PUV
Other miscellaneous syndrome
MMIHS (n = 5) 16
(12–21)
42 5 (100) 1 (20) 3 (60) 5 PD Increased NT, clubfoot NA
Smith–Lemli–Opitz
syndrome (n = 2)
22
(16–28)
NA 2 (100) 2 (100) 2 (100) 1 TOP;
1 AL
Shortened long bones,
increased NT
Urethral atresia, hypospadia,
ureteropelvic stenosis,
polydactyly, CHD, cleft
palate, micrognathia
Morris syndrome (n = 1) 35 57 0 (0) 0 (0) 1 (100) AL None
Ochoa syndrome (n = 1) 33 54 0 (0) 0 (0) 1 (100) AL None
Spinal muscular
atrophy (n = 1)
16 35 1 (100)** 0 (0) 1 (100) AL Increased NT, UCC,
absent DV, hydrops
Arthrogryposis, neurogenic
bladder
Marcus Gunn jaw
winking syndrome
(n = 1)
21 NA 0 (0) 0 (0) 1 (100) AL None PUV, VUR, duplex collecting
system
Data are given as mean (range) or n (%). *Keyhole sign, hydronephrosis, oligohydramnios. †Abnormal renal cortical appearance, oligohydramnios. ‡Keyhole
sign, abnormal renal cortical appearance, hydronephrosis, oligohydramnios. §Plus one case of polyhydramnios. ¶Plus two cases of polyhydramnios. **Keyhole
sign, abnormal renal cortical appearance. AL, alive beyond 28 days after birth; BWS, Beckwith–Wiedemann syndrome; CHD, congenital heart defect;
CRS, caudal regression syndrome; DV, ductus venosus; EFW, estimated fetal weight; FEB, fetal echogenic bowel; GA, gestational age; LBD, longitudinal
bladder diameter; LUTO, lower urinary tract obstruction; MMIHS, megacystis-microcolon-intestinal hypoperistalsis; NA, not available; NT, nuchal
translucency; OEIS, omphalocele-exstrophy-imperforate anus-spinal defect; PAS, pulmonary artery stenosis; PD, perinatal death including intrauterine fetal
demise and neonatal death; PUV, posterior urethral valves; SUA, single umbilical artery; TOP, termination of pregnancy; UCC, umbilical cord cyst; US,
ultrasound; VSD, ventricular septal defect; VUR, vesicoureteral reflux.
clinical significance, but probably unrelated to the
observed phenotypes (Table 3).
Thirty-two cases presented with a wide spectrum of
developmental abnormalities involving the anus, rectum
and urogenital tract, and were classified as having
ARM. This group included 13 fetuses with VACTERL
associations, six with cloacal malformations, seven with
OEIS complex, two with Fraser syndrome and four
with caudal regression spectrum. In fetuses with ARM,
megacystis was detected early in pregnancy (mean GA
at referral, 16 weeks). In all cases with urethral and anal
atresia, the fetal bladder was severely distended, with LBD
(in mm) equal to or greater than twice the GA (in weeks).
In cases of moderate bladder distension, with LBD lower
than GA × 2 (mm), a spinal or vertebral anomaly was
found either at the antenatal scan or at the postmortem
examination. In this group, the amniotic fluid volume was
reduced in 66% of cases.
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Fetal macrosomia was detected in six cases and an
overgrowth syndrome in four cases, which comprised
two infants with Beckwith–Wiedemann syndrome (BWS)
and two with Sotos syndrome. Five fetuses were diag-
nosed with megacystis-microcolon-intestinal hypoperi-
stalsis syndrome (MMIHS), four of which had normal
amniotic fluid volume during pregnancy. Moreover, a
similar phenotype with intestinal hypoperistalsis and
Table 4 Pregnancy outcome and postnatal renal function in 222
fetuses diagnosed with isolated lower urinary tract obstruction
(LUTO)
Outcome Value
Termination of pregnancy 54 (24)
Perinatal death* 39 (18)
Alive beyond 28 days after birth 129 (58)
Cause of obstruction (n = 181)
Posterior urethral valves 83 (46)
Urethral atresia 5 (3)
Urethral stenosis and other 93 (51)
Postnatal renal function (n = 80)
eGFR (mL/min/1.73 m2) 63 (3–162)
Severely impaired renal function
(eGFR < 30 mL/min/1.73 m2)
16 (20)
Data are expressed as n (%) or median (range). *Perinatal death
includes intrauterine demise and neonatal death. eGFR, estimated
glomerular filtration rate.
detrusor hypotonia was observed in one infant with
Ochoa syndrome. Other miscellaneous genetic and
structural anomalies observed in our cohort are reported
in Table 3.
Based on the antenatal findings and final diagnosis in
our cohort, a flowchart was designed to guide the differ-
ential diagnosis of fetal megacystis and rule out major
genetic syndromes and developmental abnormalities
(Figure 2).
In our study population, 360 fetuses had isolated mega-
cystis (megacystis without other associated ultrasound
abnormality or solely with associated signs of LUTO).
This subgroup of fetuses had a better outcome, as shown
in Figure 3. Their GA at onset of oligo- or anhydramnios
was related to the fetal outcome; this was 17 weeks in the
pregnancies that were terminated (n = 116), 20 weeks in
pregnancies that ended in intrauterine fetal demise
(n= 19), 24 weeks in those that resulted in a neonatal
death (n= 28) and 30 weeks in children that survived
(n= 197). Among the 197 surviving children, LUTO was
confirmed in 129 cases, while in 60, normal micturition or
an isolated urological anomaly (including vesicoureteral
reflux or duplex collecting system) was diagnosed.
Impaired renal function (eGFR< 60 mL/min/1.73m2)
within the first year of age was observed in 36 children
with confirmed LUTO and in only one child without
LUTO, but with severe vesicoureteral reflux.
Cloacal malformation
   (UCC)
Omphalocele
LBD > GA × 2 mm
Spine and skeleton
VACTERL association (renal, spinal,
   limb or cardiac anomalies; no gastric
   bubble; dilated colon; SUA; UCC)
CRS (increased NT; CRL shorter than
   expected; sacral agenesis)
OEIS complex
   (increased NT;
   spinal defect; SUA)
Cardiac defect
Macrosomia or
polyhydramnios
LUTO
MMIHS (thin bladder wall; dilated
   stomach and bowel loops)
VACTERL association (renal,
   spinal, limb or cardiac anomalies;
   no gastric bubble; absent perianal
 muscular complex; SUA; UCC)
Fetal megacystis
Late megacystis (≥ 18 weeks)Early megacystis (< 18 weeks)
Karyotype Aneuploidy Isolated megacystisMMHIS (thin bladder wall; dilated
   stomach and bowel loops)
22q11 deletion syndrome (CHD
  (conotruncal); cleft lip/palate;
  absent/hypoplastic thymus; large
  cavum septi pellucidi)
LUTO + CHD
VACTERL (renal, spinal, limb or
   cardiac anomalies; no gastric
   bubble; absent perianal muscular
   complex; UCC; SUA)
Overgrowth syndrome
MMHIS (thin bladder wall; dilated
    stomach and bowel loops)
Abnormal
Normal
Yes
No
Abnormal
Yes
Yes
Yes
No
No
Yes
No
No
Figure 2 Practical guide for differential diagnosis of fetal megacystis. CHD, congenital heart defect; CRL, crown–rump length; CRS, caudal
regression syndrome; GA, gestational age; LBD, longitudinal bladder diameter; LUTO, lower urinary tract obstruction; MMIHS, megacystis-
microcolon-intestinal hypoperistalsis; NT, nuchal translucency; OEIS, omphalocele-exstrophy-imperforate anus-spinal defect; SUA, single
umbilical artery; UCC, umbilical cord cyst.
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TOP (n = 116 (32%))
      Mean GA at oligo-/anhydramnios,
       17 ± 1 weeks
Normal bladder or isolated urological anomaly (n = 60)*
   eGFR < 30 mL/min/1.73 m2 (n = 0)
   30 mL/min/1.73 m2 < eGFR < 60 mL/min/1.73 m2 (n = 1)
   60 mL/min/1.73 m2 < eGFR < 90 mL/min/1.73 m2 (n = 3)
   eGFR > 90 mL/min/1.73 m2 (n = 6)
   eGFR unknown (n = 50)
IUFD (n = 19 (5%))
      Mean GA at oligo-/anhydramnios,
       20 ± 8 weeks
Neonatal death (n = 28 (8%))
      Mean GA at oligo-/anhydramnios,
       24 ± 4 weeks
Confirmed LUTO (n = 129)
   eGFR < 30 mL/min/1.73 m2 (n = 16)
   30 mL/min/1.73 m2 < eGFR < 60 mL/min/1.73 m2 (n = 20)
   60 mL/min/1.73 m2 < eGFR < 90 mL/min/1.73 m2 (n = 12)
   eGFR > 90 mL/min/1.73 m2 (n = 22)
   eGFR unknown (n = 59)
Live child (n = 197 (55%))
Mean GA at
oligo-/anhydramnios,
30 ± 5 weeks
Isolated megacystis
(n = 360)
Unclear final diagnosis (n = 8)
Figure 3 Flowchart showing outcome of 360 fetuses with isolated megacystis. *Includes fetuses without postnatal evidence of lower urinary
tract obstruction (LUTO), but normal micturition, vesicoureteral reflux or duplex collecting system. eGFR, estimated glomerular filtration
rate; GA, gestational age; IUFD, intrauterine fetal demise; TOP, termination of pregnancy.
DISCUSSION
This study shows that, although the main cause of fetal
megacystis is LUTO, an enlarged fetal bladder can also be
present as a concomitant finding in miscellaneous genetic
syndromes, developmental anomalies and chromosomal
abnormalities. The main problem in the work-up of fetal
megacystis remains its definition and the lack of a
standardized antenatal management approach3. In this
study, we provide an overview of the underlying etiologies
and propose a practical guide for the differential diagnosis
of fetuses with isolated megacystis or associated bladder
enlargement.
Fetal megacystis was an associated finding in one-third
of our cases. After exclusion of chromosomal anomalies,
the most frequently observed complex anomaly was an
ARM, diagnosed in 8% of cases. In this group, fetuses
with a cloacal malformation typically presented with
severe and early megacystis, with a LBD larger than twice
the GA. This anomaly is typically suspected in female
fetuses with distended bladder and, behind it, a single or
septate anechoic area corresponding to the vagina19–22.
In spite of a predominance in female fetuses, we confirm,
similarly to other studies14,19, that a cloacal malformation
can also occur in male fetuses.
In 81% (26/32) of cases, ARM was part of
multisystemic anomalies, such as VACTERL association,
caudal regression spectrum, OEIS complex and Fraser
syndrome. Similarly to Bornes et al.11, we diagnosed
VACTERL association and OIES complex in 20/418 (5%)
of fetuses with fetal megacystis. VACTERL association is
rarely diagnosed prenatally as the key features, such as
anorectal and esophageal atresia (with absence of gastric
bubble) are not easily detected prenatally20,21. In fact,
absent or small stomach bubble is present in less than 10%
of fetuses with esophageal atresia, owing to the presence
of a tracheoesophageal fistula in the majority of cases22.
Similarly, absence of the perianal muscular complex
in anorectal atresia is more commonly observed from
23 weeks’ gestation onwards and is not seen on the routine
20-week scan23,24. In light of this study, we advocate
that this condition be considered in the differential
diagnosis of fetal megacystis, particularly if this occurs
early in pregnancy with associated spinal, renal, limb or
cardiac defects, single umbilical artery and umbilical cord
cysts.
A second striking result of this study was the
association of fetal megacystis with fetal macrosomia
and with overgrowth syndromes, such as BWS and Sotos
syndrome. In this group, megacystis may occur owing to
a variety of causes such as obstructive polyps or posterior
urethral valves in BWS25–27 and urethral stenosis in
Sotos syndrome28, or simply owing to polyuria. Typical
© 2018 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2019; 53: 779–787.
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antenatal ultrasound features of overgrowth syndromes
have been described in detail before29, and Vora and
Bianchi proposed an algorithm to assist in the differential
diagnosis of these syndromes30. However, it should be
borne in mind that overgrowth/macrosomia is rarely
detected at the 20-week scan and in the majority of
cases the diagnosis occurs only after birth30.
MMIHS was observed in 1% of cases in our
cohort. This is a rare syndrome with poor prognosis
characterized by a distended non-obstructed bladder and
intestinal hypoperistalsis31. MMIHS is considered the
most severe form of a spectrum of chronic intestinal
pseudo-obstructive disorders, such as the more common
Hirschsprung’s disease31. The genetic basis of MMIHS
has been ascribed to a number of different autosomal
dominant and recessive mutations (ACTG2, MYH11 and
LMOD1 genes)32–34. In our study, this syndrome was
suspected in only one affected fetus, while in the remaining
cases LUTO was suspected. Prenatal diagnosis of MMIHS
is indeed challenging and successful in less than one-third
of cases35. However, discriminating MMIHS from LUTO
remains crucial because MMIHS, although usually lethal,
is rarely associated with significant renal impairment and
thus any form of prenatal bladder drainage would be
inappropriate35.
The majority of MMIHS cases in our cohort presented
with typical LUTO signs, such as megacystis and bilateral
hydronephrosis. This further highlights the importance
of considering MMIHS in the differential diagnosis of
megacystis with LUTO. To date, this syndrome is typically
suspected in female fetuses with coexisting megacystis and
normal to increased amniotic fluid volume. However, in
our cohort, fetal gender was not so relevant in predicting
MMIHS, as three out of five cases were male fetuses. This
is in keeping with a systematic review showing that 32%
of MMHIS cases occur in boys and polyhydramnios is
reported in only 27% of cases35. For this purpose, we
suggest a new clinical score to discriminate LUTO from
cases with non-obstructive megacystis (such as MMIHS),
and Tuzovic et al.35 suggested a set of typical ultrasound
signs of MMIHS, such as dilated fetal stomach, large
atonic bladder with a thin wall and dilated bowel loops
in the third trimester. As the gastrointestinal anomalies of
MMIHS are scarcely amenable to ultrasound diagnosis,
fetal magnetic resonance imaging can be of help in
detecting microcolon and dilated esophagus36. Although
the genetic basis of MMHIS is heterogeneous and most
cases are sporadic, we would recommend that, in the
presence of the abovementioned criteria, genetic testing
for MMHIS should be carried out, especially before
prenatal bladder drainage is considered.
In the subgroup of fetuses with isolated megacystis, our
outcome data support the findings of Bornes et al., with
about half (55%) surviving and about one in six (15%)
being diagnosed with vesicoureteral reflux after birth11.
However, the most important message of this study is
that fetal megacystis can be the common denominator of
many conditions other than LUTO, including complex
conditions with a poor prognosis such as chromosomal
abnormalities or ARM, while it can also be merely a
sign of isolated urological anomalies with an overall good
prognosis.
A limitation of this study is its retrospective nature.
In fact, we describe a set of fetal abnormalities and
syndromes diagnosed based on local protocols without
following a systematic protocol for invasive testing
or genetic analysis. This implies that other syndromic
cases may have been overlooked, resulting in an
underestimation of the real prevalence of syndromal
associations.
In conclusion, this study provides an overview of a
range of disorders associated with fetal megacystis and
proposes a practical guide for the prenatal differential
diagnosis of genetic syndromes and chromosomal and
developmental abnormalities in pregnancies presenting
with fetal megacystis, focusing on the morphological
examination of the fetus. This may be of help in the
antenatal work-up and counseling of fetal megacystis.
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